Allergen suppressant and allergen suppressing product
Patent Information
- Application Number
- MYPI2025001048
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-10-19
- Filing Date
- 2023-10-17
- Publication Date
- 2024-04-19
AI Technical Summary
Current allergen suppressants have insufficient effectiveness in reducing allergens such as those from dust mites and cedar pollen, which cause allergic diseases like atopic dermatitis, bronchial asthma, and allergic rhinitis, as they do not adequately neutralize or remove these allergens from living spaces.
Development of an allergen suppressant containing a compound with acidic functional groups bonded to a nitrogen atom via carbon atoms, which effectively suppresses allergen reactions by forming a high-concentration active ingredient with a content of 50% or more, preferably 95% or more, to achieve a significant allergen suppression rate of 70% or higher.
The allergen suppressant demonstrates an excellent allergen suppression effect, reducing allergen abundance by 70% or more, thereby providing a more effective solution for allergic disease management compared to existing technologies.
Abstract
Description
Allergen suppressants and allergen suppression products
[0001] The present invention relates to an allergen inhibitor and an allergen-inhibiting product.
[0002] In recent years, many allergic diseases such as atopic dermatitis, bronchial asthma, and allergic rhinitis have become a problem. The main cause of these allergic diseases is the increase in allergens in living spaces, such as mites that live in homes, particularly allergens such as Dermatophagoides pneumoniae allergens (Der1, Der2) that are abundant in house dust, and cedar pollen allergens (Cryj1, Cryj2) that are airborne in large quantities mainly in spring.
[0003] The allergens for house dust mites are not the mites themselves, but rather the corpses and feces of house dust mites, so even if house dust mites are eradicated, it will not be a fundamental solution to allergic diseases.
[0004] Furthermore, the cedar pollen allergens Cryj1 and Cryj2 are glycoproteins with molecular weights of approximately 40 kDa and approximately 37 kDa, respectively. When these cedar pollen allergens come into contact with the nasal mucosa, they are recognized as foreign substances in the body and cause an inflammatory reaction.
[0005] Therefore, there is a need for a technology that can remove allergens from living spaces or inactivate them by denaturing them.
[0006] Patent Document 1 discloses a cellulosic fiber having allergen treatment ability, characterized in that it is loaded with an allergen treatment agent containing, as an active ingredient, a nitrogen-containing compound having a specific chemical structural formula or a solvate thereof.
[0007] JP 2007-31889 A
[0008] However, the allergen treatment ability (allergen suppression effect) of the allergen treatment agent disclosed in Patent Document 1 is insufficient, and an allergen suppressor that exhibits an excellent allergen suppression effect has been desired.
[0009] The present invention provides an allergen inhibitor that exhibits excellent allergen-inhibiting effects, and an allergen-inhibiting product obtained by treating an allergen-containing object with the allergen inhibitor.
[0010] The allergen-suppressing agent of the present invention comprises an allergen-suppressing compound having one or more acidic functional groups, the acidic functional groups being bound to a nitrogen atom via one or more carbon atoms.
[0011] The allergen-suppressing product of the present invention is characterized by comprising a base material and the allergen-suppressing agent contained in the base material.
[0012] The allergen inhibitor of the present invention contains an allergen-inhibiting compound having one or more acidic functional groups, the acidic functional groups being bound to a nitrogen atom via one or more carbon atoms, and therefore can effectively inhibit the reaction of allergens with specific antibodies (allergen-inhibiting effect).
[0013] The allergen-suppressing agent of the present invention contains, as an active ingredient, an allergen-suppressing compound having one or more acidic functional groups, the acidic functional groups being bound to a nitrogen atom via one or more carbon atoms. The allergen-suppressing compounds may be used alone or in combination of two or more.
[0014] The content of the allergen-suppressing compound in the allergen inhibitor is preferably 50% by mass or more, more preferably 60% by mass or more, more preferably 70% by mass or more, more preferably 80% by mass or more, more preferably 90% by mass or more, more preferably 95% by mass or more, more preferably 99% by mass or more, and more preferably 100% by mass.
[0015] The allergen inhibitor has an excellent allergen-suppressing effect by containing an allergen-suppressing compound having one or more acidic functional groups, the acidic functional groups being bonded to a nitrogen atom via one or more carbon atoms.
[0016] Here, the term "allergen inhibitor" refers to a substance that has an allergen-suppressing effect. The allergen-suppressing effect can be determined, for example, as follows: A freeze-dried powder of an allergen is dissolved in phosphate buffer (pH 7.6) to prepare an allergen solution with a protein content of 20 μg / milliliter. The allergen may be, for example, a product commercially available from Cosmo Bio Co., Ltd. under the trade name "Mite Extract-Df."
[0017] The allergen inhibitor is diluted with ion-exchanged water to prepare a 1% by mass diluted solution of the allergen inhibitor.
[0018] Next, a test tube containing 1 milliliter of the allergen solution is prepared, and 100 microliters of the diluted allergen inhibitor solution is added to the test tube, followed by shaking at 25°C for 16 hours to prepare a test solution.
[0019] Next, the amount W1 (ng / ml) of Derf1 present in the test solution in the test tube is measured using a measuring reagent, such as the one commercially available from NichiNichi Co., Ltd. under the trade name "Mite Allergen Derf1 Measurement ELISA Kit."
[0020] In addition, the amount W0 (ng / milliliter) of Derf1 present in the test solution in the test tube is measured in the same manner as described above, except that the test solution is prepared without adding the allergen inhibitor solution to the test tube.
[0021] The allergen suppression rate (%) is then calculated based on the following formula, and if the allergen suppression rate is 60% or higher, it can be determined that the product has an allergen suppression effect: Allergen suppression rate (%) = 100 - (W1 / W0) x 100
[0022] The allergen suppression rate of the allergen suppressor is preferably 70% or more, more preferably 80% or more, more preferably 90% or more, and even more preferably 95% or more.
[0023] The content of the allergen-suppressing compound in the allergen inhibitor is preferably 80% by mass or more, more preferably 85% by mass or more, more preferably 90% by mass or more, more preferably 95% by mass or more, more preferably 99% by mass or more, and more preferably 100% by mass or more.
[0024] The number of acidic functional groups in the allergen-suppressing compound is preferably 1 to 5, more preferably 3 to 5, since this improves the allergen-suppressing effect of the allergen inhibitor.
[0025] The acidic functional group refers to a functional group capable of releasing a hydrogen ion (proton) in an aqueous solution. The acidic functional group is preferably an H-type acidic functional group. The acidic functional group is not particularly limited, and examples thereof include a carboxy group (-COOH), a sulfo group (sulfonic acid group) (-SO3H), a phosphonic acid group [-P(=O)(OH)2], and a phosphate group [-OPO(OH)2]. Since the allergen inhibitor has an excellent allergen suppression effect, the carboxy group, sulfo group, and phosphonic acid group are preferred, the carboxy group and phosphonic acid group are more preferred, and the carboxy group is more preferred.
[0026] In the allergen-suppressing compound, the acidic functional group is bonded to the nitrogen atom via one or more carbon atoms. The acidic functional group may be bonded to the nitrogen atom via one or more carbon atoms, and the carbon atom may be either a carbon atom constituting a chain skeleton or a carbon atom constituting a cyclic skeleton. However, since the allergen-suppressing effect of the allergen inhibitor is excellent, it is preferable that the carbon atom constituting the chain skeleton is included, and it is more preferable that the carbon atom constituting the chain skeleton is included. As the cyclic skeleton, an alicyclic skeleton is preferable, and a cycloalkane skeleton is preferable. The chain skeleton may also include a case where it has one carbon atom. Examples of cycloalkane skeletons include cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, cyclononane, cyclodecane, norbornene, bicyclo[1.1.0]butane, bicyclo[1.1.1]pentane, bicyclo[2.1.0]pentane, bicyclo[2.1.1]hexane, bicyclo[3.1.0]hexane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, adamantane, diamantane, and decahydronaphthalene.
[0027] The content of nitrogen atoms in the allergen-suppressing compound is preferably 5% or more, more preferably 6% or more. The content of nitrogen atoms in the allergen-suppressing compound is preferably 12% or less, more preferably 11% or less. When the content of nitrogen atoms in the allergen-suppressing compound is within the above range, the acidic functional group and the nitrogen atom of the allergen-suppressing compound interact appropriately within the molecule, improving the allergen-suppressing effect of the allergen inhibitor.
[0028] The nitrogen atom content (%) in the allergen-suppressing compound is a value calculated based on the following formula: When the allergen-suppressing compound forms a hydrate, the number of water (HO) molecules is not included in the sum of the atomic weights of all atoms constituting the allergen-suppressing compound. Nitrogen atom content (%) = 100 x (sum of atomic weights of all nitrogen atoms in the allergen-suppressing compound) / (sum of atomic weights of all atoms constituting the allergen-suppressing compound)
[0029] The pH of a 0.5% by mass aqueous solution of the allergen-suppressing compound at 25°C is preferably 4.5 or less, since this makes it easier to maintain the acidity of the acidic functional groups of the allergen-suppressing compound and improves the allergen-suppressing effect of the allergen inhibitor.
[0030] The allergen-suppressing compound is preferably a compound represented by the following formula (1) or (2). First, the allergen-suppressing compound having the structural formula represented by formula (1) will be described. The allergen-suppressing compound represented by formula (1) may form a hydrate.
[0031]
[0032] In formula (1), R 1 are each independently a hydrogen atom, -CH-R 3 or -A 1 -R 3 In the allergen-suppressing compound, R 1 There are two R 1 may be the same or different from each other. 3 represents a carboxy group, a phosphonic acid group, or a sulfo group, and is preferably a carboxy group or a phosphonic acid group, more preferably a carboxy group, since the allergen-suppressing effect of the allergen inhibitor is improved.
[0033] A 1 represents a divalent substituent formed by removing (pulling out) two hydrogen atoms from a carbon atom of a 4-, 5-, or 6-membered ring. The carbon atoms removing the hydrogen atoms may be the same or different from each other. The carbon atom from which the hydrogen atom is removed (pulled out) is a carbon atom that directly constitutes the 4-, 5-, or 6-membered ring, and does not include carbon atoms that constitute a substituent bonded to the 4-, 5-, or 6-membered ring. The hydrogen atoms bonded to the carbon atoms of the 4-, 5-, and 6-membered ring may be substituted with a substituent (e.g., an alkyl group, etc.). A 1 is preferably a divalent substituent formed by removing (abtracting) two hydrogen atoms from a carbon atom of a benzene ring, an alicyclic four-membered ring, an alicyclic five-membered ring, or an alicyclic six-membered ring. 1is more preferably a divalent substituent resulting from removing (abtracting) two hydrogen atoms from a carbon atom of a benzene ring, cyclobutane, cyclopentane, or cyclohexane.
[0034] R 2 is -CH2-R 4 or -A 2 -R 4 Represents R 4 represents a carboxy group, a phosphonic acid group, or a sulfo group, and is preferably a carboxy group or a phosphonic acid group, more preferably a carboxy group, since the allergen-suppressing effect of the allergen inhibitor is improved.
[0035] A 2 represents a divalent substituent formed by removing (pulling out) two hydrogen atoms from a carbon atom of a 4-, 5-, or 6-membered ring. The carbon atoms removing the hydrogen atoms may be the same or different from each other. The carbon atom from which the hydrogen atom is removed (pulled out) is a carbon atom that directly constitutes the 4-, 5-, or 6-membered ring, and does not include carbon atoms that constitute a substituent bonded to the 4-, 5-, or 6-membered ring. The hydrogen atoms bonded to the carbon atoms of the 4-, 5-, and 6-membered ring may be substituted with a substituent (e.g., an alkyl group, etc.). A 2 is preferably a divalent substituent formed by removing (abtracting) two hydrogen atoms from a carbon atom of a benzene ring, an alicyclic four-membered ring, an alicyclic five-membered ring, or an alicyclic six-membered ring. 2 is preferably a divalent substituent formed by removing (abstraction) two hydrogen atoms from a carbon atom of a benzene ring, cyclobutane, cyclopentane, or cyclohexane.
[0036] In formula (1), the allergen suppression effect of the allergen suppressor is improved, so R 1 are each independently —CH—R 3 Preferably, —CH—COOH or —CH—P(═O)(OH) is more preferred, and —CH—COOH is even more preferred. 1 may be the same or different from each other.
[0037] In formula (1), the allergen suppression effect of the allergen suppressor is improved, so R2 is -CH2-R 4 is preferred, with —CH2—COOH or —CH2—P(═O)(OH)2 being more preferred, and —CH2—COOH being more preferred.
[0038] In formula (1), the allergen suppression effect of the allergen suppressor is improved, so R 1 and R 2 Preferably, two or more of the substituents are —CH—COOH. That is, the allergen-suppressing compound represented by formula (1) is preferably triglycolaminic acid [formula (5)] or iminodiacetic acid [formula (18)].
[0039]
[0040]
[0041] In formula (1), A 2 is preferably a divalent substituent formed by removing (abtracting) two hydrogen atoms from the carbon atoms of a four-membered or five-membered ring, since this improves the allergen-suppressing effect of the allergen inhibitor, and more preferably a divalent substituent formed by removing (abtracting) two hydrogen atoms from the carbon atoms of cyclobutane or cyclopentane.
[0042] In formula (1), the allergen suppression effect of the allergen suppressor is improved, so R 2 Ga-A 2 -R 4 And two R 1 In formula (1), it is preferable that both R 2 Ga-A 2 -R 4 So, A 2 is a divalent substituent formed by removing (abtracting) two hydrogen atoms from a carbon atom of a five- or six-membered ring, and two R 1 It is more preferable that both of R 2 Ga-A 2 -R 4 So, A 2 is a divalent substituent formed by removing (abtracting) two hydrogen atoms from a carbon atom of a benzene ring, an alicyclic five-membered ring, or an alicyclic six-membered ring, and two R 1It is more preferable that both of R 2 Ga-A 2 -R 4 So, A 2 is a divalent substituent formed by removing (abtracting) two hydrogen atoms from a carbon atom of benzene, cyclopentane, or cyclohexane, and two R 1 In formula (1), it is preferable that both R 2 Ga-A 2 -R 4 So, A 2 is a divalent substituent resulting from removing (abtracting) two hydrogen atoms from a carbon atom of benzene or cyclohexane, and two R 1 It is more preferable that both of are hydrogen atoms.
[0043] In formula (1), R 2 Ga-A 2 -R 4 And two R 1 are both hydrogen atoms, examples of the allergen-suppressing compound include 1-amino-1-cyclobutanecarboxylic acid [formula (6)], cycloleucine [formula (7)], 1-aminocyclohexanecarboxylic acid [formula (8)], 3-aminocyclohexanecarboxylic acid [formula (9)], 4-aminobenzoic acid [formula (15)], 3-aminobenzoic acid [formula (16)], and 2-aminobenzoic acid [formula (17)], with 4-aminobenzoic acid [formula (15)] being preferred.
[0044]
[0045] Next, the allergen-suppressing compound having the structural formula represented by formula (2) will be described. The allergen-suppressing compound represented by formula (2) may form a hydrate.
[0046]
[0047] In formula (2), R 5 is a hydrogen atom, -CH-R 7 or a structure represented by formula (3). 5 At least two R 5 is -CH2-R 7 or has a structure represented by formula (3).5 may be the same or different from each other. 7 represents a carboxy group, a phosphonic acid group, or a sulfo group. 6 represents —(CH2)n- or a structure represented by formula (4), where n is an integer of 1 to 3.
[0048] In formula (3), R 8 represents a carboxy group, a phosphonic acid group, or a sulfo group. 9 represents a carboxy group, a phosphonic acid group, or a sulfo group. 7 ~R 9 may be the same or different from each other.
[0049]
[0050] In formula (4), R 10 represents a carboxy group, a phosphonic acid group, or a sulfo group, where m is an integer of 1 to 3, and p is an integer of 1 to 3.
[0051] In formula (2), R 7 is preferably a carboxy group or a phosphonic acid group, more preferably a carboxy group, since this improves the allergen-suppressing effect of the allergen inhibitor.
[0052] In formula (2), the allergen suppression effect of the allergen suppressor is improved, so that four R 5 is -CH2-R 7 It is preferable that:
[0053] In formula (2), the allergen suppression effect of the allergen suppressor is improved, so that two R 5 is a structure represented by formula (3) and the other two R 5 is preferably a hydrogen atom, and one of the nitrogen atoms is preferably R 5 and a hydrogen atom is bonded to the other nitrogen atom, and R 5 It is more preferable that the substituent having the structure represented by formula (3) and a hydrogen atom are bonded to the group.
[0054] In formula (2), the allergen suppression effect of the allergen suppressor is improved, so that two R5 One of the R 5 has a structure represented by formula (3) and the other R 5 is preferably a hydrogen atom.
[0055] In formula (3), R 8 and R 9 are preferably a carboxy group or a phosphonic acid group, and more preferably a carboxy group, since these groups improve the allergen-suppressing effect of the allergen inhibitor.
[0056] In formula (2), R 6 is preferably —(CH2)n-, more preferably —(CH2)2- or —(CH2)3-, since this improves the allergen-suppressing effect of the allergen inhibitor.
[0057] In formula (4), R 10 is preferably a carboxy group or a phosphonic acid group, more preferably a carboxy group, since this improves the allergen-suppressing effect of the allergen inhibitor.
[0058] Preferred allergen-suppressing compounds represented by formula (2) include ethylenediaminetetraacetic acid [formula (10)], 1,3-diaminopropanetetraacetic acid [formula (11)], ethylenediaminedisuccinic acid [formula (12)], diethylenetriaminepentaacetic acid [formula (13)], and ethylenediaminetetra(methylenephosphonic acid) [formula (14)].
[0059]
[0060] The allergen inhibitor contains an allergen-suppressing compound as an active ingredient, but the method for producing the allergen inhibitor is not particularly limited, and the allergen inhibitor can be produced by mixing the allergen-suppressing compound with compounds to be added as needed in a general manner.
[0061] Next, the usage of the allergen inhibitor will be described. The allergen inhibitor exerts an allergen-suppressing effect against various allergens by the action of the allergen-suppressing compound.
[0062] Allergens targeted by allergen inhibitors include animal allergens such as house dust mite allergens (Der1, Der2) and allergens caused by dogs and cats (Can f1, Fel d1), as well as airborne cedar pollen allergens (Cryj1, Cryj2) and plant allergens such as pollen. Particularly effective animal allergens include allergens from mites (mites are organisms of the Arthropoda class - order Acari, which are divided into seven main suborders: dorsal stigmata represented by Dermestida, tetrastigmata represented by hard mites, posterior stigmata represented by Ixodes ovatus and Ornithoides spp., middle stigmata represented by house mites and Passer mites, anterior stigmata represented by Lunanese Cheyletidylus and Tarsus cruzi, house dust mites such as Dermatophagoides farinae, astigmata represented by Tyrophagus putrescentiae, and cryptostigmata represented by Ornithoides nigricans and Neospora nigricans). However, it is particularly effective against house dust mites, which are abundant in house dust, especially in bedding, and cause allergic diseases.
[0063] The allergen inhibitor may be attached (supported) to the surface of base particles. By attaching the allergen-suppressing compound to the surface of the base particles, the allergen inhibitor can be uniformly dispersed in the substrate described below without forming agglomerates. Therefore, the surface area of the allergen inhibitor can be increased, the contact between the allergen inhibitor and the allergen can be sufficiently ensured, and the allergen-suppressing effect of the allergen inhibitor can be fully exerted.
[0064] The base particles to which the allergen inhibitor is attached are not particularly limited as long as they do not inhibit the allergen-suppressing effect of the allergen inhibitor. Base particles include resin particles and inorganic particles. The base particles may be used alone or in combination of two or more types.
[0065] Examples of synthetic resins constituting the resin particles include styrene-based resins, acrylic-based resins, urethane-based resins, vinyl chloride-based resins, ABS resins; and synthetic rubbers such as styrene-butadiene rubber (SBR) and nitrile-butadiene rubber (NBR). Acrylic-based resins and styrene-based resins are preferred, and polystyrene is more preferred.
[0066] The styrene-based resin is not particularly limited, and examples thereof include homopolymers or copolymers containing, as monomer units, styrene-based monomers such as styrene, methylstyrene, ethylstyrene, i-propylstyrene, dimethylstyrene, chlorostyrene, and bromostyrene, and copolymers containing, as monomer units, a styrene-based monomer and one or more vinyl monomers copolymerizable with the styrene-based monomer.
[0067] Examples of vinyl monomers copolymerizable with styrene-based monomers include acrylic monomers such as acrylonitrile, methacrylonitrile, acrylic acid, methacrylic acid, acrylic acid esters (e.g., methyl acrylate, ethyl acrylate, butyl acrylate), methacrylic acid esters (e.g., methyl methacrylate, ethyl methacrylate, butyl methacrylate), maleic anhydride, and acrylamide.
[0068] The acrylic resin is not particularly limited, and examples thereof include homopolymers or copolymers containing, as monomer units, acrylic monomers such as methyl (meth)acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, and pentyl (meth)acrylate, and copolymers containing, as monomer units, an acrylic monomer and one or more vinyl monomers copolymerizable with the acrylic monomer. Note that (meth)acrylate means acrylate or methacrylate.
[0069] Examples of vinyl monomers copolymerizable with acrylic monomers include acrylonitrile, methacrylonitrile, maleic anhydride, and acrylamide.
[0070] The inorganic compound (inorganic material) constituting the inorganic particles is not particularly limited, and examples thereof include zeolite, hydrotalcite, calcium carbonate, calcium citrate, magnesium carbonate, and magnesium hydroxide.
[0071] The synthetic resin constituting the resin particles preferably contains an aromatic ring, which attracts the hydrophobic moiety of the allergen-suppressing compound attached to the surface of the resin particles and orients the acidic functional groups outward, thereby enabling the allergen-suppressing effect of the allergen inhibitor to be more effectively exerted.
[0072] The aromatic ring may be a monocyclic aromatic ring, or may be a condensed aromatic ring formed by condensing monocyclic aromatic rings. The aromatic ring is not particularly limited, and examples thereof include a benzene ring, a naphthalene ring, an anthracene ring, biphenyl, and phenoxyphenyl. The aromatic ring is formed by abstracting one or more hydrogen atoms from the carbon atoms directly constituting the aromatic ring or the condensed aromatic ring, and bonding to other atoms via a covalent bond.
[0073] The amount of the allergen-suppressing compound attached to the base particles is preferably 1 part by mass or more, more preferably 5 parts by mass or more, more preferably 7 parts by mass or more, and even more preferably 10 parts by mass or more, per 100 parts by mass of the base particles. When the amount of the allergen-suppressing compound attached is 1 part by mass or more, the allergen inhibitor can be uniformly attached to the surface of the base particles, and the allergen-suppressing effect of the allergen inhibitor can be more effectively exerted.
[0074] The amount of the allergen-suppressing compound attached to the base particle is preferably 50 parts by mass or less, more preferably 40 parts by mass or less, more preferably 30 parts by mass or less, and even more preferably 20 parts by mass or less, per 100 parts by mass of the base particle. When the amount of the allergen-suppressing compound attached is 50 parts by mass or less, the allergen inhibitors are not bonded to each other, and the allergen inhibitors are efficiently arranged on the surface of the base particle, improving the allergen-suppressing effect.
[0075] The method for attaching the allergen inhibitor to the surface of the base particle is not particularly limited, and may be, for example, by the adhesive strength of the allergen inhibitor, or by using a binder resin to adhere the allergen inhibitor to the surface of the base particle. However, since this allows the allergen-suppressing effect of the allergen inhibitor to be effectively exerted, it is preferable that the allergen-suppressing compound be attached to the surface of the base particle by the adhesive strength of the allergen-suppressing compound itself.
[0076] The allergen inhibitor is used, for example, by being incorporated into a substrate to which an allergen-suppressing effect is to be imparted, thereby constituting an allergen-suppressing product. The substrate containing the allergen inhibitor exhibits the allergen-suppressing effect as an allergen-suppressing product. The form in which the allergen inhibitor is incorporated into the substrate is not particularly limited, and examples include a form in which the allergen inhibitor is attached to the surface of the substrate, or a form in which the allergen inhibitor is kneaded into the substrate.
[0077] The allergen inhibitor can be attached to the surface of the substrate by dissolving or dispersing the allergen inhibitor in a solvent to form an allergen inhibitor solution or allergen inhibitor dispersion, and then applying this allergen inhibitor solution or allergen inhibitor dispersion to the substrate.
[0078] Examples of the solvent include water (preferably ion-exchanged water), alcohols (methyl alcohol, ethyl alcohol, propyl alcohol, etc.), hydrocarbons (toluene, xylene, methylnaphthalene, kerosene, cyclohexane, etc.), ethers (diethyl ether, tetrahydrofuran, dioxane, etc.), ketones (acetone, methyl ethyl ketone, etc.), and amides (N,N-dimethylformamide, etc.), with water and alcohols being preferred.
[0079] The allergen inhibitor solution or dispersion may be attached to the surface of a substrate by spraying, i.e., the allergen inhibitor solution or dispersion may be filled in a spray-type spray container and used.
[0080] The content of the allergen inhibitor in 100% by mass of the allergen inhibitor solution is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and even more preferably 1% by mass or more. The content of the allergen inhibitor in 100% by mass of the allergen inhibitor solution is preferably 40% by mass or less, and more preferably 30% by mass or less.
[0081] The allergen inhibitor solution may contain additives such as water-soluble agents, oily agents, emulsions, and suspensions, if necessary.
[0082] The content of the allergen inhibitor in 100% by mass of the allergen inhibitor dispersion is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and even more preferably 1% by mass or more. The content of the allergen inhibitor in 100% by mass of the allergen inhibitor dispersion is preferably 40% by mass or less, and more preferably 30% by mass or less.
[0083] The allergen inhibitor dispersion may contain additives such as a dispersant and a thickener, if necessary.
[0084] Examples of dispersants include surfactants such as anionic surfactants, cationic surfactants, nonionic surfactants, and amphoteric surfactants. Anionic surfactants are preferred as dispersants because they improve the dispersibility of the allergen inhibitor in the solution.
[0085] Examples of the anionic surfactant include alkylbenzenesulfonates, salts of naphthalenesulfonic acid-formalin condensates, aromatic sulfonates such as polystyrene sulfonates, alkanesulfonates, α-sulfofatty acid salts, alkylsulfosuccinates, α-olefinsulfonates, alkyl sulfates, alkyl sulfate ester salts, alkyl ethoxy sulfate ester salts, and phosphate ester salts.
[0086] Cationic surfactants include, for example, fatty amine salts, quaternary ammonium salts, alkylpyridinium salts, and the like.
[0087] Examples of nonionic surfactants include polyoxyethylenes obtained by polymerizing and adding an oligomer-phenol complex, such as styrene, propylene or butylene, or tribenzyl phenol to polyoxyethylene; polyoxyethylene derivatives such as long-chain alkyl-phenyl ethers of polyoxyethylene, such as polyoxyethylene octylphenyl ether and polyoxyethylene nonylphenyl ether; polyoxyalkylene alkyl ethers, polyoxyalkylene fatty acid esters, polyoxyethylene polyhydric alcohol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, fatty acid monoglycerides, glycerin fatty acid esters, sorbitan fatty acid esters, sucrose fatty acid esters, and fatty acid alkanolamides.
[0088] Examples of amphoteric surfactants include tertiary amine oxides, betaines, and alkyl betaines.
[0089] The thickener may be a natural polymer compound or a synthetic polymer compound. Examples of natural polymer compounds include pectin, gelatin, carrageenan, xanthan gum, gum arabic, glucomannan, gellan gum, and alginic acid. Examples of synthetic polymer compounds include polyethylene glycol, polyvinyl alcohol, and polyacrylic acid.
[0090] The substrate into which the allergen inhibitor is to be incorporated is not particularly limited as long as it is capable of incorporating the allergen inhibitor, and examples thereof include synthetic resin molded bodies, paints, coating films, wallpaper, decorative sheets, flooring materials, fibers, textile products (woven fabrics, nonwoven fabrics, knitted fabrics), interior and interior materials for vehicles (e.g., cars, airplanes, ships, etc.) (seats, child seats, and the foams that make these up), kitchenware, baby products, and architectural interior materials.
[0091] The building interior materials are not particularly limited, and examples thereof include flooring materials, wallpaper, ceiling materials, paints, doorknobs, switches, switch covers, wax, and the like.
[0092] The vehicle interior goods and materials are not particularly limited, and examples thereof include seats, child seats, seat belts, car mats, seat covers, doors, ceiling materials, floor mats, door trim, instrument panels, consoles, glove boxes, handrails, and the like.
[0093] The synthetic resin constituting the synthetic resin molded body is not particularly limited, and examples thereof include thermoplastic resins (e.g., polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyvinyl acetate, polyurethane, Teflon (registered trademark), acrylonitrile butadiene styrene resin, acrylonitrile styrene resin, acrylic resin, polyvinyl alcohol, polyamide, polyacetal, polycarbonate, modified polyphenylene ether, polyester, polyethylene terephthalate, polybutylene terephthalate, cyclic polyolefin, polyphenylene sulfide, polytetrafluoroethylene, polysulfone, polyethersulfone, polyarylate, polyether ether ketone, thermoplastic polyimide, polyamide imide, etc.), thermosetting resins (e.g., phenolic resin, epoxy resin, melamine resin, urea resin, unsaturated polyester resin, alkyd resin, silicone resin, polyurethane, thermosetting polyimide, etc.). The synthetic resins may be used alone or in combination of two or more.
[0094] The allergen inhibitor may be kneaded into a synthetic resin. A method for kneading the allergen inhibitor into a synthetic resin involves mixing the allergen inhibitor with a synthetic resin raw material to prepare a resin composition, and then using this resin composition to obtain an allergen-suppressed product of a desired shape as a molded article using a general-purpose synthetic resin molding method. Examples of general-purpose synthetic resin molding methods include extrusion molding, injection molding, and blow molding. The synthetic resin and the allergen inhibitor may be mixed to form a synthetic resin molding masterbatch containing the synthetic resin and the allergen inhibitor, and the synthetic resin molding masterbatch may be mixed with the synthetic resin raw material to produce the allergen-suppressed product as a synthetic resin molded body using a general-purpose synthetic resin molding method.
[0095] The content of the allergen inhibitor in 100% by mass of the synthetic resin molding masterbatch is preferably 5% by mass or more, more preferably 10% by mass or more, and is preferably 80% by mass or less, more preferably 70% by mass or less.
[0096] The content of the allergen inhibitor in 100% by mass of the synthetic resin molded product is preferably 1% by mass or more, more preferably 3% by mass or more, and is preferably 40% by mass or less, more preferably 30% by mass or less, in 100% by mass of the synthetic resin molded product.
[0097] The allergen-suppressing fiber may be produced by physically fixing the allergen inhibitor to the fiber. Examples of methods for physically fixing the allergen inhibitor to the fiber include: (1) dissolving or dispersing the allergen inhibitor in a solvent to prepare an allergen inhibitor solution, and then immersing the fiber in the allergen inhibitor solution to impregnate the fiber with the allergen inhibitor solution; (2) applying or spraying the allergen inhibitor solution to the fiber surface; (3) immersing the fiber in a binder resin in which the allergen inhibitor is dissolved or dispersed to fix the allergen inhibitor to the fiber via the binder resin; and (4) applying or spraying the binder resin in which the allergen inhibitor is dissolved or dispersed to the fiber surface to fix the allergen inhibitor to the fiber via the binder resin. In the above methods (1) and (2), the allergen inhibitor solution may contain a binder resin. The solvent is the same as described above, so a description thereof will be omitted.
[0098] The binder resin is not particularly limited as long as it can fix the allergen inhibitor to the fiber surface. For example, examples of the binder resin include urethane-based resins such as one-component urethane resins and two-component urethane resins, silicone-based resins, acrylic resins, urethane acrylate resins, polyester resins, unsaturated polyester resins, alkyd resins, vinyl acetate resins, vinyl chloride resins, epoxy resins, and epoxy acrylate resins, with urethane-based resins being preferred.
[0099] The allergen inhibitor may be incorporated into a paint and used as an allergen-suppressing paint. Conventional paints are used as the paint, including oil-based paints (e.g., blended paints, oil varnishes, etc.), cellulose paints, and synthetic resin paints. The paint also includes photocurable paints that polymerize upon irradiation with radiation such as ultraviolet light to produce a binder resin.
[0100] The paint may contain additives such as pigments, plasticizers, curing agents, extenders, fillers, antioxidants, thickeners, surfactants, etc., within limits that do not impair the paint's physical properties. Examples of methods for incorporating the allergen inhibitor into the paint include a method in which the allergen inhibitor and the paint are supplied to a dispersing device and uniformly mixed. Examples of dispersing devices include a high-speed mill, a ball mill, and a sand mill.
[0101] The content of the allergen inhibitor in 100% by mass of the allergen-suppressing paint is preferably 1% by mass or more, more preferably 3% by mass or more, and even more preferably 5% by mass or more. The content of the allergen inhibitor in 100% by mass of the allergen-suppressing paint is preferably 40% by mass or less, and more preferably 30% by mass or less.
[0102] The content of the allergen inhibitor in 100% by mass of the allergen-suppressing product is preferably 1% by mass or more, more preferably 3% by mass or more, and even more preferably 5% by mass or more. The content of the allergen inhibitor in 100% by mass of the allergen-suppressing paint is preferably 40% by mass or less, and more preferably 30% by mass or less.
[0103] The present invention will be described in more detail below using examples, but the present invention is not limited to these examples.
[0104] The following compounds were prepared as allergen-suppressing compounds. These allergen-suppressing compounds were used as allergen-suppressing agents.
[0105] 4-Aminobenzoic acid, triglycolaminic acid [formula (5)], 1,3-diaminopropanetetraacetic acid [formula (11)], diethylenetriaminepentaacetic acid [formula (13)], iminodiacetic acid [formula (18)], ethylenediaminedisuccinic acid trihydrate [trihydrate of the compound represented by formula (12)], ethylenediaminetetra(methylenephosphonic acid) [formula (14)], sebacic acid, suberic acid, benzoic acid, diammonium iron diethylenetriaminepentaacetate
[0106] The nitrogen atom content in the allergen-suppressing compound and the pH of a 0.5% by mass aqueous solution of the allergen-suppressing compound at 25°C are shown in Table 1 under the columns "Nitrogen content" and "pH (25°C)", respectively.
[0107] Examples 1 to 7 and Comparative Examples 1 to 4 Allergen inhibitors containing the allergen-suppressing compounds (100% by mass) shown in Table 2 were prepared.
[0108] The allergen inhibitors were subjected to anti-allergen tests using mite allergen (Derf1) and pollen allergen (Cryj1), and the results are shown in Table 2.
[0109] (Drug - Antiallergen Test) [Mite Allergen] Freeze-dried powder of mite allergen (Derf1) (manufactured by Cosmo Bio Co., Ltd., product name "Mite Extract-Df") was dissolved in phosphate buffer (pH 7.6) to prepare an allergen solution with a protein content of 20 μg / milliliter.
[0110] Ion-exchanged water was added to the allergen inhibitor containing the allergen-suppressing compound to prepare a diluted allergen inhibitor solution having an allergen-suppressing compound concentration of 1% by mass.
[0111] Next, a test tube containing 1 milliliter of the allergen solution was prepared, and 100 microliters of the diluted allergen inhibitor solution was added to the test tube, followed by shaking at 25°C for 16 hours to prepare a test solution.
[0112] Next, the amount W1 (ng / ml) of Derf1 present in the test solution in the test tube was measured using a measurement reagent (manufactured by Nichinichi Co., Ltd., trade name "Mite Allergen Derf1 Measurement ELISA Kit").
[0113] In addition, the amount of Derf1 present in the test solution in the test tube, W0 (ng / milliliter), was measured in the same manner as described above, except that the test solution was prepared without adding the allergen inhibitor solution to the test tube.
[0114] The allergen suppression rate (%) was calculated based on the following formula. The results are shown in the "Dust mite (Derf1)" column of "Allergen suppression rate (%)" in Table 2. Allergen suppression rate (%) = 100 - (W1 / W0) x 100
[0115] [Pollen allergen] The allergen inhibition rate was measured in the same manner as when using mite allergen (Derf1), except that freeze-dried powder of pollen allergen (Cryj1) (manufactured by ITEA, product name "Cedar pollen extract") was used instead of mite allergen (Derf1), and the measurement reagent (manufactured by Nichinici, product name "Mite allergen Derf1 measurement ELISA kit") was used instead of the measurement reagent (manufactured by Nichinici, product name "Cedar pollen allergen Cryj1 measurement ELISA kit"). The obtained results are shown in the "Pollen (Cryj1)" column of "Drug" in "Allergen inhibition rate (%)" in Table 2.
[0116] (Coating Film - Antiallergen Test) The mite allergen (Derf1) and measurement reagent, and the pollen allergen (Cryj1) and measurement reagent used were the same as those used in the above (Drug - Antiallergen Test).
[0117] An allergen-inhibiting paint was prepared by adding 90 parts by mass of binder resin (Showa Denko K.K., trade name "Polysol AM-200", solvent: water, solids content: 40% by mass) to 10 parts by mass of the allergen inhibitor obtained in the Examples and Comparative Examples. Next, a polyester film was prepared as a substrate. The allergen-inhibiting paint was applied to one side of this substrate so that the film thickness after drying would be 10 μm, and then dried in an oven at 120°C for 1 hour to prepare an allergen-inhibiting product with a coating film formed on one side.
[0118] The freeze-dried powders of the allergens were dissolved separately in purified water to prepare aqueous allergen solutions containing 10 μg / mL of allergen. PBS-T (phosphate buffer containing 0.05% by mass of Tween 20 (Tokyo Chemical Industry Co., Ltd.), pH 7.4) was then added to the aqueous allergen solutions and mixed uniformly to prepare an allergen solution containing 15 ng / mL of allergen.
[0119] The allergen-suppressing product was cut into a 5 cm square shape, 0.4 mL of the allergen solution was dropped onto the coating, and the product was then covered with a 4 cm square polyethylene film and left to stand for 24 hours at 25°C to prepare a test solution. The amount of allergen present in the test solution, W1 (ng / mL), was then measured using the measurement reagent.
[0120] A blank product with a coating film formed on one side was prepared in the same manner as above, except that a binder resin (Showa Denko K.K., product name "Polysol AM-200", solvent: water, solids content: 40% by mass) was used as the blank paint instead of the allergen-suppressing paint. The amount of allergen present in the test solution, W0 (ng / mL), was measured in the same manner as above, except that the blank product was used instead of the allergen-suppressing product. The allergen suppression rate (%) was calculated based on the following formula. The results obtained are shown in the "Dust Mite (Derf1)" and "Pollen (Cryj1)" columns under "Coating Film" in the "Allergen suppression rate (%)" section of Table 2. Allergen suppression rate (%) = 100 - (W1 / W0) x 100
[0121] (Fiber-Antiallergen Test) The mite allergen (Derf1) and measurement reagent, and the pollen allergen (Cryj1) and measurement reagent used were the same as those used in the above (Drug-Antiallergen Test).
[0122] Purified water was added to 1 g of the allergen inhibitor obtained in each of the Examples and Comparative Examples and mixed uniformly to prepare an allergen inhibitor dispersion containing 1% by mass of the allergen inhibitor.
[0123] Next, as a substrate, polyester fiber (manufactured by Shikisen Co., Ltd., product name "Polyester Tropical Toray", basis weight: 120 g / m 2The fibers were immersed in 100 g of the allergen inhibitor dispersion for 2 minutes. The immersed polyester fibers were squeezed with a manual mangle and dried at 120°C for 10 minutes to produce allergen-suppressing fibers in which the allergen inhibitor was fixed to the polyester fibers. In the allergen-suppressing fibers, the allergen inhibitor was fixed at 1 g / m 2 It was contained.
[0124] The freeze-dried powders of the allergens were dissolved separately in purified water to prepare aqueous allergen solutions containing 10 μg / mL of allergen. PBS-T (phosphate buffer containing 0.05% by mass of Tween 20 (Tokyo Chemical Industry Co., Ltd.), pH 7.4) was then added to the aqueous allergen solutions and mixed uniformly to prepare an allergen solution containing 15 ng / mL of allergen.
[0125] 0.4 g of the allergen-suppressing fiber was placed in a zippered plastic bag, and 1 mL of the above allergen solution was dropped into it. The bag was then sealed and left to stand at 25° C. for 2 hours to prepare a test solution.
[0126] Next, the amount W1 (ng / mL) of the allergen present in the test solution was measured using the above-mentioned measuring reagent.
[0127] The amount of allergen present in the test solution, W0 (ng / mL), was measured in the same manner as above, except that no allergen-suppressing fiber was placed in the zippered plastic bag. The allergen suppression rate (%) was calculated based on the following formula. The results obtained are shown in the "Allergen suppression rate (%)" columns for "Fiber", "Dust mite (Derf1)" and "Pollen (Cryj1)" in Table 2. Allergen suppression rate (%) = 100 - (W1 / W0) x 100
[0128] (Spray - Anti-allergen Test) Five parts by mass of the allergen inhibitors obtained in Examples 1, 5, and 6, and Comparative Examples 1 and 4, 5 parts by mass of polyethylene glycol (Mw7500, manufactured by Wako Pure Chemical Industries, Ltd.), and 90 parts by mass of water were mixed to prepare an aqueous solution of the allergen inhibitor. The obtained aqueous solution of the allergen inhibitor was filled into a spray container and applied to polyester fiber (manufactured by Shikisen Co., Ltd., trade name "Polyester Tropical Toray", basis weight: 120 g / m2) at a concentration of 4 μL / cm2. 2The mixture was left to dry at room temperature for 8 hours to prepare an allergen-suppressing fiber.
[0129] Using the obtained allergen-inhibiting fiber, the allergen inhibition rate (%) was calculated in the same manner as described above (Fiber - Antiallergen Test). The results obtained are shown in the "Allergen inhibition rate (%)" columns of "Spray" for "Dust mite (Derf1)" and "Pollen (Cryj1)" in Table 2.
[0130] (Molded Article - Anti-Allergen Test) The mite allergen (Derf1) and measurement reagent, and the pollen allergen (Cryj1) and measurement reagent used were the same as those used in the above (Drug - Anti-Allergen Test).
[0131] 50 parts by mass of each of the allergen inhibitors obtained in Examples 2 to 5 and Comparative Examples 1 to 3 and 50 parts by mass of polypropylene (manufactured by Japan Polypropylene Corporation, trade name "Novatec PP BC6C") were melt-kneaded and mixed to prepare a masterbatch for synthetic resin molding.
[0132] A resin composition was prepared by melt-kneading 30 parts by mass of the synthetic resin molding masterbatch obtained and 70 parts by mass of separately prepared polypropylene (trade name "Novatec PP BC6C" manufactured by Japan Polypropylene Corporation) at 180°C for 5 minutes. The obtained resin composition was press-molded to obtain a sheet-like synthetic resin molded product with an average thickness of 1 mm.
[0133] Also, a sheet-like synthetic resin molding consisting of only polypropylene (trade name "Novatec PP BC6C" manufactured by Japan Polypropylene Corporation) having an average thickness of 1 mm was prepared, and this synthetic resin molding was used as a blank synthetic resin molding.
[0134] Using the synthetic resin molded article containing the allergen inhibitor and the blank synthetic resin molded article, the allergen inhibition rate (%) was calculated in the same manner as described above (Coating film - anti-allergen test). The results obtained are shown in the "Allergen inhibition rate (%)" columns of "Molded article", "Dust mite (Derf1)" and "Pollen (Cryj1)", respectively, in Table 2.
[0135]
[0136]
[0137] The allergen inhibitor of the present invention can effectively inhibit the reaction of allergens with specific antibodies. By incorporating the allergen inhibitor into a base material, it is possible to produce an allergen-suppressing product with excellent allergen-suppressing effect.
[0138] (Cross-reference to related applications) This application claims priority based on Japanese Patent Application No. 2022-167899, filed on October 19, 2022, the disclosure of which is incorporated herein by reference in its entirety.
Claims
1. An allergen inhibitor characterized by comprising an allergen-suppressing compound having one or more acidic functional groups, said acidic functional groups being bound to a nitrogen atom via one or more carbon atoms.
2. The allergen inhibitor according to claim 1, wherein the acidic functional group is a carboxyl group, a phosphonic acid group, or a sulfo group.
3. An allergen inhibitor according to claim 1 or 2, characterized in that the allergen-suppressing compound is represented by formula (1). [In formula (1), R 1 are each independently a hydrogen atom, -CH-R 3 or -A 1 -R 3 and two R 1 may be the same or different from each other. 3 represents a carboxy group, a phosphonic acid group, or a sulfo group. 1 represents a divalent substituent formed by removing two hydrogen atoms from a carbon atom of a 4-, 5-, or 6-membered ring. 2 is -CH2-R 4 or -A 2 -R 4 Represents R 4 represents a carboxy group, a phosphonic acid group, or a sulfo group. 2 represents a divalent substituent formed by removing two hydrogen atoms from a carbon atom of a 4-, 5-, or 6-membered ring.
4. An allergen inhibitor according to claim 1 or 2, characterized in that the allergen-suppressing compound is represented by formula (2). [In formula (2), R 5 is a hydrogen atom, -CH-R 7 or a structure represented by formula (3), and at least two R 5 is -CH2-R 7 or has a structure represented by formula (3). 5 may be the same or different from each other. 7 ~R 9 R each represents a carboxy group, a phosphonic acid group, or a sulfo group. 6 represents —(CH)— or a structure represented by formula (4), where n is an integer of 1 to 3. [In formula (4), R 10 represents a carboxy group, a phosphonic acid group, or a sulfo group, wherein m is an integer of 1 to 3, and p is an integer of 1 to 3.
5. An allergen inhibitor according to claim 1 or 2, characterized in that the acidic functional group is a carboxyl group or a phosphonic acid group.
6. The allergen inhibitor according to claim 1 or 2, characterized in that the content of nitrogen atoms in the allergen-suppressing compound is 5 to 12%.
7. An allergen inhibitor according to claim 1 or 2, characterized in that the acidic functional group is a carboxy group.
8. An allergen inhibitor according to claim 1 or 2, characterized in that the pH of a 0.5% by mass aqueous solution of the allergen-suppressing compound at 25°C is 4.5 or less.
9. An allergen-suppressing product comprising a base material and the allergen-suppressing agent according to claim 1 or 2 contained in the base material.
